Digital Additional Risk Minimization Measures: An Exploratory Study Using Qualitative Feedback from Healthcare Professionals and Patients Across Six Countries

BACKGROUND: Additional risk minimization measures (aRMMs) are required for some pharmaceutical products when routine risk minimization measures (i.e., product labeling) are deemed insufficient. Measures often include educational materials, such as paper brochures, leaflets, and/or alert cards that p...

Descripción completa

Detalles Bibliográficos
Autores principales: Da Silva-Tillmann, Barbara, Wilson, Marie-Claire, Doshi, Hetal, Lievano, Fabio, Perrott, Mark, Renz, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744394/
https://www.ncbi.nlm.nih.gov/pubmed/35006578
http://dx.doi.org/10.1007/s40290-021-00415-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744394/
https://www.ncbi.nlm.nih.gov/pubmed/35006578
http://dx.doi.org/10.1007/s40290-021-00415-7

Ejemplares similares